Stay updated with breaking news from David Rueda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.K. regulators have approved the use of a CRISPR therapy called Casgevy to treat two inherited blood disorders. But what is it and how does it work?
The United Kingdom is the first country to approve the use of the world's first gene therapy for treating sickle cell disease and beta-thalassemia.
The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive. The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.
A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive
National recognition and respect for Asian Americans is surging, and yet, racial violence against Asian Americans is rising as well. Rather than seeing these as opposing trends, it makes more sense